FDA reassures rare disease advocates that ‘being flexible’ is plan for gene therapy At roundtable, Kennedy, Prasad, and others express openness to quick approvals

https://www.statnews.com/2025/06/06/fda-appears-open-to-relaxed-regulations-on-rare-disease-gene-therapy/